Navigation Links
Intake of vitamin E during pregnancy influences asthma risk in kids

According to a new study, low vitamin E intake by mothers during pregnancy may heighten asthma risk in their kids by the age of 5.//

Dr. Graham Devereux, of the department of environmental and occupational medicine at the University of Aberdeen, Scotland and his team conducted this study. This study was based on the findings of an earlier study conducted by the same team. Previously, they had reported that kids at the age of 2, whose mothers had low vitamin E intake during pregnancy, were more prone to wheezing, in spite of being healthy otherwise.

"This is part of a body of work that indicates that sufficient vitamin E intake is probably important," said Devereux. This recent study is published in the September issue of the American Journal of Respiratory and Critical Care Medicine.

The study was conducted on around 1,250 pregnant women attending neo-natal clinics in Scotland between 1997 and 1999. Evaluation of maternal dietary intake from conception and medical histories associated with asthma, wheezing and related respiratory issues were done. The same details were collected from their kids up to the age of 5.

The team found that there was no connection between an increased wheezing or asthma risk and maternal intake of vitamin C, beta-carotene, magnesium, copper, and iron during pregnancy.

However, an increased risk for developing persistent asthma among kids, from the first 2 years up to the age of 5 was related to the low intake of vitamin E by the mother during pregnancy.

Mothers rated in the last 20% for prenatal vitamin E intake gave birth to kids who were 5 times more prone to asthma than the kids born to mothers in the top 20%. Asthma risk is not influenced by that child’s diet at the age of 5 reported the researchers.

They explained that development of fetal airways is completed by 16th week of gestation. This implies that certain dietary deficiencies, specificall
'"/>




Page: 1 2

Related medicine news :

1. Dangers of Low Calcium Intake
2. Caffeine Intake May reduce Insulin Sensitivity
3. Robo-Dog To Monitor Your Calorie Intake
4. Intake Of Processed Meat And Fat Associated With Pancreatic Cancer
5. Excess Intake of Alcohol Results in Permanent DNA Damage.
6. Intake of a healthy and balanced diet: miracle for old people.
7. Newborns Affected By Antidepressant Intake Of Mothers
8. Salt & Its Intake Causes a Strong debate In UK
9. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
10. Viewing TV During Lunch Affects Childrens Food Intake
11. TV Viewing Increases Intake of Junk Food
Post Your Comments:
(Date:12/6/2009)... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ... of Hematology meeting Dec. 7, 2009, in New Orleans. ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/5/2009)... three-drug combination has shown in a phase 1/2 ... in the treatment of patients newly diagnosed with multiple ... marrow, say researchers from Dana-Farber Cancer Institute. , Partial ... 66 patients treated with the drug combination in the ... partial response rate" in the phase 2 population, reports ...
(Date:12/5/2009)... --In Youngest Babies, This Type of Blood Cancer Is ... Dec. 5 Pediatric oncologists have identified specific genes, ... drive an often-fatal form of leukemia in infants. By ... better predict which infants may benefit from particular treatments. ...
(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... healthcare real estate company providing ... hospitals and physicians ... CHARLOTTE, N.C., Jan. 23 Cogdell Spencer Inc.,(NYSE: ... agreement,to acquire 100 percent of the stock of Marshall Erdman ...
... [Brown University] When faced with even a ... fewer women receive these potentially life-saving breast cancer ... University and Harvard Medical School researchers. , In ... insurance co-payments and mammography rates, researchers found that ...
... 23 Pennsylvania,AFL-CIO President William George and Secretary ... decisions by,Representatives John Peterson, Joseph Pitts, and William ... millions of children in,families hit hardest by our ... in the face of a severe economic downturn,Representatives ...
... Jan. 23 Johnson & Johnson,Pharmaceutical Research & ... Drug Application (NDA) to the U.S. Food and ... an investigational oral analgesic for the relief of ... American Pain Foundation, more than 25 million,Americans experience ...
... Jan. 23 Boston Scientific (NYSE: BSX ),today ... Chief,Medical and Scientific Officer, on an article in the ... and Drug-Eluting Stents for,Off-Label Indications.", "The analysis from ... in today,s New England Journal of Medicine is the ...
... went five years without anti-rejection drugs , , WEDNESDAY, ... transplant recipients to stop taking powerful immunosuppressive drugs are ... in the development of the transplant field is to ... the lifesaving benefit of the transplant without the costs ...
Other Medicine News:Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 2Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 3Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 4Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 5Health News:Health insurance co-payments deter mammography use 2Health News:Health insurance co-payments deter mammography use 3Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Boston Scientific Comments on New England Journal of Medicine Article 2Health News:Boston Scientific Comments on New England Journal of Medicine Article 3Health News:New Therapies Could Change Organ Transplants 2Health News:New Therapies Could Change Organ Transplants 3
(Date:12/4/2009)... N.Y., Dec. 4 Bayer Diabetes Care today announced the ... Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the ... the country. The grand prize is an in-person meeting today ... 1 diabetes like Nick, are: Caleb, age 6, from Danbury, ...
(Date:12/4/2009)... AZN ) today announced that the US Food ... (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment ... SEROQUEL XR is the only medication in its class ... disorder as adjunctive therapy and acute depressive episodes associated ...
(Date:12/3/2009)... Mass., Dec. 3 Allen Medical Systems, a subsidiary ... today announced the launch of its new Allen Amatech(TM) ... . ,, The website reinforces the Allen ... the new product catalog, with detailed descriptions and design ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2By 2018 GlaxoSmithKlines Votrient Will Garner Sales of 24640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader 57010 1By 2018 GlaxoSmithKlines Votrient Will Garner Sales of 24640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader 57010 2Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 1Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 2Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 3Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 1Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 2Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 3Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 4Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 5
... Sanofi-aventis,announced that the U.S. Food and Drug ... in combination with cisplatin,and 5-fluorouracil for induction ... the head and neck (SCCHN) before patients ... its approval on the results of the ...
... AppyScore(TM), the First Blood-based Screen / Triage Test for Human,Appendicitis, ... ... Sensitivity Level of 98%., CASTLE ROCK, Colo., Sept. ... bio-pharmaceutical company dedicated to the,development of novel drugs and diagnostics ...
Other Medicine Technology:Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 2Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 3Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 4AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 2AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 3AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 4AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 5AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 6AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 7AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 8AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study 9
Used for complex diagnostic and interventional procedures....
... St. Jude Medical offers a ... for use with percutaneous catheter ... of intravascular catheters. Our diagnostic ... lengths and incorporate a proprietary ...
... VISION Coronary Stent System is Guidant's first ... stents. Cobalt chromium is stronger and more ... chromium stent can have similar strength and ... with struts that are only .0032" thick. ...
... The CYPHER Sirolimus-eluting Coronary ... antiproliferative drug, called "sirolimus", a ... stent delivery platform. Upon placement, ... wall and impedes the process ...
Medicine Products: